Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • BW TV
  • Subscribe to Print

Latest Articles in Covishield

Covishield And Covaxin Doses To Cost Rs 225 Now In Private Hospitals

The Serum Institute of India has cut the rates of Covishield from ₹600 to ₹225 per dose, while Bharat Biotech has brought down the price of Covaxin from ₹1,200 to ₹225

Read More

SII Urges Mandaviya To Reduce Gap Between 2nd, Precaution Dose Of Covishield From 9 To 3 Months

In a letter to Mandaviya, Prakash Kumar Singh, Director, Government and Regulatory Affairs, SII, is learnt to stated that the third dose of COVID-19 vaccine is being administered within 6 months of the second dose in various countries and this schedule is giving very good results to control the infection, an official source said.

Read More

Reports Claiming 50L Unused Covishield Doses May Go Waste By Month End 'Misleading': Govt

States were advised that they could try interventions such as administration of vaccine under Corporate Social Responsibility or vaccination at subsidised rates in private hospitals, the health ministry stated.

Read More

India's Expert Panel Advises Full Approval For Covishield, Covaxin

Covaxin and Covishield received emergency use authorisation in India in January 2021, with more than a combined 1.5 billion doses having been administered so far, according to government data.

Read More

Govt Expert Panel Recommends Regular Market Approval For Covishield, Covaxin

Pharma companies Serum Institute of India (SII) and Bharat Biotech had submitted applications to the Drugs Controller General of India (DCGI) seeking regular market authorisation for their respective COVID-19 vaccines Covishield and Covaxin.

Read More

Serum Institute Urges Govt To Fast-Track Movement Of Its COVID-19 Vaccine Covishield

The Serum Institute will commence its Covid vaccine export under the COVAX programme from November 23 and Nepal will receive the first lot of Covishiled on November 24.

Read More

Govt Allows Serum Institute To Export 50L Covishield Doses To 4 Nations

In addition to these three countries, the SII will also export Covishield to Bangladesh under COVAX, they said.

Read More

Serum Institute Of India Seeks Regular Marketing Authorisation From DCGI For Covishield

The cumulative COVID-19 vaccines administered in the country has exceeded 102.27 crore.

Read More

Centre Got Over 65.25 Crore Covishield Doses, 9.1 Crore Covaxin Jabs Till September 19

The SII has informed the government that it will be able to supply around 22 crore doses of Covishield in October.

Read More

India Raises Concern Over UK's Non-Recognition Of Covishield, Says Its ‘Discriminating Policy’

"The non-recogition of Covishield is a discriminating policy and impacts our citizens travelling to the UK. The External Affairs Minister has raised the issue strongly with the new UK foreign secretary."

Read More

Calls For UK To Review COVID Vaccine Protocol For Indian Travellers

The current traffic light system of red, amber and green countries based on levels of COVID-19 risk will be scrapped and replaced with one red list only.

Read More

NTAGI Likely To Consider Reducing Gap Between Two Doses Of Covishield: Sources

The government in May had further extended the gap between the two doses of Covishield from 6-8 weeks to 12-16 weeks and said the decision to increase the gap was based on scientific evidence.

Read More

Mixing Of Covaxin & Covishield: Efficacy Check

The puzzling question that is arising as of now is about the contrasting effects of the two vaccines on protection and potency.

Read More

Only Marginal Difference In Purchase Price Of Covishield, Covaxin For Centre: MoS Health

The total doses of vaccine that would be available to a state and UT, is provided to them 15 days in advance, so as to enable them to plan for acceleration of vaccination coverage while being cognizant of the available vaccines

Read More

Delhi Covid Vaccine Stock To Last Less Than One Day: Bulletin

As many as 93,83,468 vaccine doses have been administered in the national capital till date, including 22,25,292 are second doses.

Read More